States with the highest hepatitis C virus (HCV) infection rates are set to get an influx
Called HepConnect, the program will support evidence-based solutions to meet the need of Americans most affected by the opioid crisis in Indiana, Kentucky, North Carolina, Tennessee
“We are committed to ensuring these resources generate maximum impact by reaching organizations and programs operating on the front lines,” said Monique Tula, executive director of the Harm Reduction Coalition. “We’re thrilled about Gilead’s commitment to innovation and proud to collaborate with them to deepen harm reduction work that will make a meaningful difference for people affected by HCV across greater Appalachia.”
According to the Centers for Disease Control and Prevention, new hepatitis C infections have more than tripled throughout Appalachia between 2006 and 2012, largely as a result of an increase in injection drug use. To learn more about hepatitis C in Appalachia, click here.